🇺🇸 PFE — Pfizer Inc.

Salud Compra
← Volver

Precio actual

29,39 USD

Máx. histórico

61,25

1786 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-52,02%

Rango 52 semanas

23,62 – 31,44

Variación hoy

-0,20%

Cierre anterior

29,88

Rango de hoy

28,54 – 29,43

Volumen hoy

48.232.765

Peor caída histórica

-69,25%

12/04/1999 → 02/03/2009

Recuperado en 1717 días

Volatilidad anualizada ⓘ

27,33%

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
75.000
PER ⓘ
41,99 (puede no estar actualizado)
Dividend yield
5,76% (puede no estar actualizado)
Precio objetivo analistas
29,72 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 2 días
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,2900 USD · Yield: 4,39%
Fecha de pago Importe por participación
03/08/2011 0,1898 USD
11/05/2011 0,1898 USD
02/02/2011 0,1898 USD
04/11/2010 0,1708 USD
04/08/2010 0,1708 USD
05/05/2010 0,1708 USD
03/02/2010 0,1708 USD
04/11/2009 0,1518 USD
05/08/2009 0,1518 USD
06/05/2009 0,1518 USD
04/02/2009 0,3036 USD
05/11/2008 0,3036 USD
06/08/2008 0,3036 USD
07/05/2008 0,3036 USD
06/02/2008 0,3036 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
10/02/1998 25,81 26,57 25,76 26,57 +4,03% 3,14% 11.460.985
09/02/1998 25,70 25,87 25,36 25,54 -0,15% 2,00% 7.468.328
06/02/1998 25,30 25,74 25,28 25,58 +1,41% 1,80% 7.305.169
05/02/1998 25,93 26,03 25,18 25,22 -2,00% 3,28% 9.176.440
04/02/1998 25,93 26,01 25,62 25,74 -1,44% 1,52% 7.188.175
03/02/1998 26,09 26,21 25,79 26,11 -0,08% 1,59% 9.601.729
02/02/1998 26,78 26,90 26,05 26,13 +1,07% 3,17% 13.720.550
30/01/1998 25,91 25,97 25,54 25,85 +0,38% 1,68% 7.249.517
29/01/1998 25,46 26,07 25,38 25,76 +2,04% 2,72% 10.593.965
28/01/1998 25,14 25,62 25,12 25,24 +1,43% 1,97% 12.162.317
27/01/1998 24,69 25,20 24,63 24,89 +1,21% 2,32% 8.980.080
26/01/1998 24,69 24,98 24,51 24,59 -0,40% 1,92% 7.326.670
23/01/1998 24,73 24,89 24,23 24,69 -0,72% 2,64% 8.812.810
22/01/1998 24,79 25,18 24,73 24,87 -0,47% 1,83% 7.924.288
21/01/1998 25,32 25,38 24,83 24,98 -2,24% 2,19% 11.910.305
20/01/1998 24,79 25,58 24,67 25,56 +4,95% 3,67% 16.171.733
16/01/1998 24,11 24,35 23,92 24,35 +1,57% 1,80% 11.845.168
15/01/1998 24,47 24,49 23,92 23,98 -2,57% 2,34% 8.811.862
14/01/1998 24,61 24,67 24,21 24,61 +0,65% 1,85% 8.174.086
13/01/1998 24,67 24,67 24,35 24,45 +1,14% 1,28% 9.229.246
12/01/1998 22,47 24,35 22,47 24,17 +3,38% 8,36% 12.809.262
09/01/1998 24,43 24,47 22,77 23,38 -4,75% 6,96% 12.672.347
08/01/1998 24,71 25,10 24,41 24,55 -0,64% 2,80% 10.525.349
07/01/1998 24,35 24,71 24,09 24,71 +1,13% 2,52% 7.016.162
06/01/1998 24,98 25,12 24,39 24,43 -3,21% 2,93% 9.301.339
05/01/1998 24,31 25,28 24,13 25,24 +5,45% 4,72% 14.369.709
02/01/1998 23,86 23,96 23,40 23,94 +1,51% 2,32% 4.809.402
31/12/1997 23,96 24,11 23,44 23,58 -1,32% 2,81% 5.163.862
30/12/1997 23,40 24,00 23,40 23,90 +2,63% 2,53% 5.829.147
29/12/1997 23,03 23,40 22,97 23,28 +2,35% 1,89% 4.417.630